Using FAPI-PET to diagnose pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial uses a special imaging scan called FAPI-PET to help doctors better diagnose pancreatic cancer. If you are suspected of having pancreatic cancer or a recurrence, this study may help confirm or clarify your diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old
- You have a suspected new or returning pancreatic cancer
- You are well enough to be up and about (WHO performance score 0-2)
- You can understand and sign a consent form
- You are not pregnant, breastfeeding, or in a vulnerable group as defined by Finnish law
- You do not have a medical condition that would prevent a full-body PET/CT scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a special PET/CT scan called FAPI PET/CT to see how well it can detect or track cancerous tumors. It may help doctors better understand your cancer without extra procedures.
This trial uses a special PET scan (FAPi PET) to see if it can help spot pancreatic ductal adenocarcinoma better than standard scans. It may offer a more precise way to check the extent of the disease.
This trial tests a new imaging agent (18F-FAPI) to see if it can help find tumors early in people with lung, thyroid, pancreatic, melanoma, or neuroendocrine cancers.
This study tests whether a special PET scan can better show how well chemotherapy given directly into the abdomen is working, compared to standard scans. This may help doctors see changes in tumors earlier and guide treatment.
This study tests a new imaging agent (68Ga-FAPI-46) to see if it can better show the extent of pancreatic cancer before surgery. It may help doctors plan your surgery more accurately.
This trial tests a new type of PET scan (FAPI-PET) to see if it can better find colon cancer that has spread to lymph nodes or other parts of the body. It may help doctors plan the right treatment for you.
Hear when a new Positron Emission Tomography trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.